- Home
- FNWB vs NRXS Comparison
FNWB vs NRXS Comparison
Compare FNWB & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | FNWB | NRXS |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 78.9M |
| IPO Year | 2012 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FNWB | NRXS |
|---|---|---|
| Price | $8.99 | $7.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.50 | $13.00 |
| AVG Volume (30 Days) | 34.5K | ★ 208.7K |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | ★ 36.00 | 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | $176,000.00 | ★ $3,569,282.00 |
| Revenue This Year | $19.24 | $142.91 |
| Revenue Next Year | $8.90 | $120.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $7.05 | $1.33 |
| 52 Week High | $10.98 | $7.97 |
Technical Indicators
Market Signals| Indicator | FNWB | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 58.87 |
| Support Level | $7.56 | $2.36 |
| Resistance Level | $9.00 | $7.97 |
| Average True Range (ATR) | 0.29 | 0.72 |
| MACD | 0.05 | -0.06 |
| Stochastic Oscillator | 67.28 | 61.14 |
Price Performance
Historical ComparisonAbout FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).